{"doc_id": "PMID-7510691.txt", "sent_id": "S1", "tokens": ["The", "interleukin-8", "AP-1", "and", "kappa", "B-like", "sites", "are", "genetic", "end", "targets", "of", "FK506", "-", "sensitive", "pathway", "accompanied", "by", "calcium", "mobilization", "."], "sentence": "The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506 - sensitive pathway accompanied by calcium mobilization .", "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "targets", "start": 10, "end": 10}, "arguments": [{"entity_id": "T1", "text": "interleukin-8", "role": "Theme"}]}, {"id": "E2", "event_type": "Regulation", "trigger": {"text": "targets", "start": 10, "end": 10}, "arguments": [{"entity_id": "T1", "text": "interleukin-8", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "interleukin-8", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T20", "text": "targets", "entity_type": "Regulation", "start": 10, "end": 10}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "", "tokens": ["FK506", ",", "an", "immunosuppressant", ",", "inhibits", "the", "production", "of", "several", "cytokines", "in", "T", "lymphocytes", "."], "sentence": "FK506 , an immunosuppressant , inhibits the production of several cytokines in T lymphocytes .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-7510691.txt", "sent_id": "S3", "tokens": ["We", "observed", "that", "FK506", "suppressed", "the", "transcription", "of", "a", "chemotactic", "cytokine", ",", "interleukin-8", "(", "IL-8", ")", "in", "a", "human", "T", "cell", "line", ",", "Jurkat", "cells", ",", "activated", "by", "phorbol", "12-myristate", "13-acetate", "(", "PMA", ")", "and", "calcium", "(", "Ca2+", ")", "ionophore", "(", "ionomycin", ")", "."], "sentence": "We observed that FK506 suppressed the transcription of a chemotactic cytokine , interleukin-8 ( IL-8 ) in a human T cell line , Jurkat cells , activated by phorbol 12-myristate 13-acetate ( PMA ) and calcium ( Ca2+ ) ionophore ( ionomycin ) .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "suppressed", "start": 4, "end": 4}, "arguments": [{"entity_id": "T22", "text": "transcription", "role": "Theme"}]}, {"id": "E4", "event_type": "Transcription", "trigger": {"text": "transcription", "start": 6, "end": 6}, "arguments": [{"entity_id": "T3", "text": "IL-8", "role": "Theme"}]}], "entity_mentions": [{"id": "T2", "text": "interleukin-8", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T3", "text": "IL-8", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T21", "text": "suppressed", "entity_type": "Negative_regulation", "start": 4, "end": 4}, {"id": "T22", "text": "transcription", "entity_type": "Transcription", "start": 6, "end": 6}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "S4", "tokens": ["By", "deleted", "and", "mutated", "analysis", "of", "the", "IL-8", "promoters", ",", "the", "AP-1", "and", "kappa", "B-like", "sites", "were", "identified", "as", "the", "responsive", "elements", "for", "PMA", "and", "ionomycin", "."], "sentence": "By deleted and mutated analysis of the IL-8 promoters , the AP-1 and kappa B-like sites were identified as the responsive elements for PMA and ionomycin .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "IL-8", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "", "tokens": ["FK506", "suppressed", "the", "transcriptions", "through", "the", "AP-1", "or", "kappa", "B-like", "sites", "induced", "by", "PMA", "plus", "Ca", "(", "2+", ")", "-", "mobilizing", "agents", ",", "but", "not", "those", "induced", "by", "Ca", "(", "2+", ")", "-", "independent", "stimuli", "."], "sentence": "FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca ( 2+ ) - mobilizing agents , but not those induced by Ca ( 2+ ) - independent stimuli .", "event_mentions": [], "entity_mentions": [{"id": "T23", "text": "suppressed", "entity_type": "Negative_regulation", "start": 1, "end": 1}, {"id": "T24", "text": "through", "entity_type": "Positive_regulation", "start": 4, "end": 4}, {"id": "T25", "text": "induced", "entity_type": "Positive_regulation", "start": 11, "end": 11}, {"id": "T26", "text": "induced", "entity_type": "Positive_regulation", "start": 26, "end": 26}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "S6", "tokens": ["In", "gel", "retardation", "analysis", ",", "FK506", "had", "little", "effect", "on", "the", "binding", "to", "the", "AP-1", "site", "of", "PMA", "/", "ionomycin", "-", "induced", "nuclear", "factors", ",", "which", "were", "recognized", "with", "anti", "-", "JunD", "or", "c-Fos", "antibody", "."], "sentence": "In gel retardation analysis , FK506 had little effect on the binding to the AP-1 site of PMA / ionomycin - induced nuclear factors , which were recognized with anti - JunD or c-Fos antibody .", "event_mentions": [{"id": "E10", "event_type": "Binding", "trigger": {"text": "recognized", "start": 27, "end": 27}, "arguments": [{"entity_id": "T6", "text": "c-Fos", "role": "Theme"}]}], "entity_mentions": [{"id": "T5", "text": "JunD", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T6", "text": "c-Fos", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T27", "text": "recognized", "entity_type": "Binding", "start": 27, "end": 27}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "S7", "tokens": ["In", "contrast", ",", "FK506", "or", "EGTA", "(", "Ca2+", "chelator", ")", "similarly", "affected", "the", "formation", "of", "kappa", "B-like", "site", "binding", "complexes", ",", "which", "were", "not", "recognized", "by", "any", "antibodies", "against", "the", "human", "Rel", "family", "proteins", "(", "c-Rel", ",", "p65", ",", "p50", ",", "and", "p49", ")", "."], "sentence": "In contrast , FK506 or EGTA ( Ca2+ chelator ) similarly affected the formation of kappa B-like site binding complexes , which were not recognized by any antibodies against the human Rel family proteins ( c-Rel , p65 , p50 , and p49 ) .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "c-Rel", "entity_type": "Protein", "start": 35, "end": 35}, {"id": "T8", "text": "p65", "entity_type": "Protein", "start": 37, "end": 37}, {"id": "T9", "text": "p50", "entity_type": "Protein", "start": 39, "end": 39}, {"id": "T10", "text": "p49", "entity_type": "Protein", "start": 42, "end": 42}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "S8", "tokens": ["Furthermore", ",", "we", "confirmed", "the", "previous", "report", "that", "FK506", "suppressed", "the", "PMA", "/", "ionomycin", "-", "induced", "activation", "through", "authentic", "kappa", "B", "site", "of", "immunoglobulin", "(", "Ig", ")", "gene", ",", "to", "which", "NF-kappa", "B", "binding", "was", "also", "decreased", "by", "FK506", ",", "indicating", "that", "both", "IL-8", "kappa", "B-like", "site", "and", "Ig", "kappa", "B", "site", "are", "FK506", "-", "sensitive", "in", "spite", "of", "the", "difference", "of", "binding", "factors", "."], "sentence": "Furthermore , we confirmed the previous report that FK506 suppressed the PMA / ionomycin - induced activation through authentic kappa B site of immunoglobulin ( Ig ) gene , to which NF-kappa B binding was also decreased by FK506 , indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506 - sensitive in spite of the difference of binding factors .", "event_mentions": [], "entity_mentions": [{"id": "T11", "text": "IL-8", "entity_type": "Protein", "start": 43, "end": 43}, {"id": "T12", "text": "Ig kappa B", "entity_type": "Protein", "start": 48, "end": 50}]}
{"doc_id": "PMID-7510691.txt", "sent_id": "S9", "tokens": ["Our", "results", "indicate", "that", "not", "only", "the", "reported", "IL-2", "NF-AT", "and", "NFIL-2A", "sites", "and", "Ig", "kappa", "B", "site", ",", "but", "also", "the", "IL-8", "AP-1", "and", "kappa", "B-like", "sites", "are", "terminals", "of", "FK506", "-", "sensitive", "pathway", "involving", "Ca2+", "mobilization", "."], "sentence": "Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site , but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .", "event_mentions": [{"id": "E11", "event_type": "Regulation", "trigger": {"text": "terminals", "start": 29, "end": 29}, "arguments": [{"entity_id": "T17", "text": "IL-8", "role": "Theme"}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "terminals", "start": 29, "end": 29}, "arguments": [{"entity_id": "T17", "text": "IL-8", "role": "Theme"}]}], "entity_mentions": [{"id": "T13", "text": "IL-2", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T14", "text": "NF-AT", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T15", "text": "NFIL-2A", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T16", "text": "Ig kappa B", "entity_type": "Protein", "start": 14, "end": 16}, {"id": "T17", "text": "IL-8", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T30", "text": "terminals", "entity_type": "Regulation", "start": 29, "end": 29}]}
